article thumbnail

Healthcare data management: resolving consent, compliance, and privacy issues

Pharmaceutical Technology

This can also potentially cause operational issues for providers and undermine trust in the doctor-patient relationship, making patients hesitant to share data in future. Furthermore, data regulations around the world add another burden of compliance and need careful management. It's a very satisfying feeling.”.

article thumbnail

Hidden compliance risks for life sciences companies

pharmaphorum

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson. A decade ago, life sciences firms were early adopters of robust compliance technology — far ahead of other industries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Running Through Life with Type 1 Diabetes

Worldwide Clinical Trials

By; Brooke Kaplan, Director, People Partner- HR Compliance & Human Capital Initiatives In April 2007, at 19 years old, I was a sophomore at the University of Maryland. I always kept up with my doctor’s appointments and insulin. Then in 2019, my doctor suggested a continuous glucose monitor (CGM) for better control.

Insulin 162
article thumbnail

Email Marketing Campaigns for Pharma: Boost Engagement & Compliance

Pharma Marketing Network

This guide explores the best strategies for boosting engagement while ensuring compliance , helping pharma brands connect with their audiences more effectively. Why Pharma Needs Email Marketing Direct Access to HCPs : Doctors, pharmacists, and researchers check their emails frequently for industry updates and medical advancements.

article thumbnail

Grand Rounds December 13, 2024: Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial (Gbenga Ogedegbe, MD, MPH, FACP)

Rethinking Clinical Trials

The fidelity to the NCM intervention, measured by the participation in 20 NCM calls and the compliance with HBPTM, was around 68% – a decent figure given the challenges of conducting a trial in a real-world setting, Dr. Ogedegbe noted.

Nurses 100
article thumbnail

UK doctors call for tighter rules on coronavirus antibody tests

pharmaphorum

Doctors have called for rules to be tightened on coronavirus antibody tests in the UK amid fears that false readings could put the public at risk. The doctors said the tests should not be used without professional support, must give accurate results and be “properly readable”. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Doctors 73
article thumbnail

Should pharma be in the app business?

World of DTC Marketing

For example, an app to help patients track MS symptoms may help patients but will it increase compliance? But at the same time, 93% of doctors believe mHealth apps can improve patients’ health. 56% of doctors have initiated the use of these tools and 26% of patients have asked about these tools. Medication management.

Doctors 230